Trends in the adoption of medications for alcohol dependence.

Trends in the adoption of medications for alcohol dependence. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Trends in the adoption of medications for alcohol dependence. Abstract Text:

Lori J Ducharme,Hannah K Knudsen,Paul M Roman,

Increasing attention is being paid to the development and dissemination of effective pharmacotherapies for the treatment of alcohol and other drug dependence. However, numerous structural and philosophical barriers impede the widespread adoption of these treatment approaches in everyday clinical practice. Research is needed to understand and overcome this gap. Drawing upon data collected from 2 large samples of substance abuse treatment providers at multiple time points, this article examines the prevalence and correlates of the adoption of the currently available pharmacotherapies for alcohol dependence: disulfiram, oral naltrexone, and acamprosate. These data suggest that the proportion of treatment programs using pharmacotherapies for alcohol dependence has been declining over time. In addition, the proportion of patients to whom these medications are prescribed is notably low. The adoption of disulfiram and naltrexone is significantly more likely in programs that are accredited, employ at least 1 physician, offer integrated care for patients with co-occurring psychiatric conditions, derive proportionately more revenue from commercial insurance payers, and have fewer linkages with the criminal justice system. Preliminary data suggest that the early adoption of acamprosate is following a similar pattern. Recommendations for addressing challenges to the diffusion of pharmacotherapies for alcohol dependence are presented.

Trends in the adoption of medications for alcohol dependence. Publishing Authors By Initials

LJ Ducharme,HK Knudsen,PM Roman,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

Trends in the adoption of medications for alcohol dependence. Journal Published:

PUBLICATION TYPE: Review

Journal: Journal of clinical psychopharmacology

VOLUME: 26 Suppl 1

Page Numbers: S13-9

Journal Abbreviation:

ISSN: 0271-0749

DAY: 3

MONTH: Dec

YEAR: 2006

Trends in the adoption of medications for alcohol dependence. Information

Number of References: 33

LANGUAGE: eng

NlmUniqueID: 8109496

Trends in the adoption of medications for alcohol dependence. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Trends in the adoption of medications for alcohol dependence. Information

Substance Name: Disulfiram

Registry Number: 97-77-8

Grant and Affiliation Information for Trends in the adoption of medications for alcohol dependence.

AFFILIATION: Institute for Behavioral Research, University of Georgia, Athens, GA 30602-2401, USA. lorid@uga.edu

Country: United States

AGENCY: United States NIDA

GRANT: R01DA14487

ACRONYM: DA

MEDLINETA: J Clin Psychopharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Trends in the adoption of medications for alcohol dependence Related Publications

• Acrylic injectable and self-curing formulations for the local release of bisphosphonates in bone tissue.
• Alveolar type II cells from ethanol-fed rats produce a fibronectin-enriched extracellular matrix that promotes monocyte activation.
• Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents.
• Black thyroid syndrome.
• Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis.
• Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics.
• Counselor emotional exhaustion and turnover intention in therapeutic communities.
• Editorial commentary.
• Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
• Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.
• Environmental neurology: a promising new field of practice and research.
• Environmental vascular risk factors: new perspectives for stroke prevention.
• Exploratory activity in Drosophila requires the kurtz nonvisual arrestin.
• Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta.
• Increased fibronectin expression in lung in the setting of chronic alcohol abuse.
• Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
• Nicotine alters lung branching morphogenesis through the alpha7 nicotinic acetylcholine receptor.
• Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
• Racial and ethnic disparities in SSRI availability in substance abuse treatment.
• Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma.
• Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine.
• Research participation and turnover intention: An exploratory analysis of substance abuse counselors.
• Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
• Roman tunnelling tool.
• The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.
• The effects of caffeine on the preterm sheep ductus arteriosus.
• The selfless geneticist.
• The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment.
• Trends in the adoption of medications for alcohol dependence.
• [Neurocysticercosis: a public health perspective]